Shoulder Innovations, Inc. (SI)
NYSE: SI · Real-Time Price · USD
13.30
+0.16 (1.22%)
Aug 14, 2025, 8:40 AM - Market open

Company Description

Shoulder Innovations, Inc. designs, develops, manufactures, and distributes implant replacement systems for shoulder arthroplasty in the United States.

It designs InSet Glenoid technology that aims to reduce mechanical stress at the bone implant interface, improve fixation mechanics, enhance stability, and reduce micromotion.

The company was incorporated in 2009 and is headquartered in Grand Rapids, Michigan.

Shoulder Innovations, Inc.
Country United States
Founded 2009
IPO Date Jul 31, 2025
Industry Medical Devices
Sector Healthcare
Employees 56
CEO Robert Ball

Contact Details

Address:
1535 Steele Avenue SW, Suite B
Grand Rapids, Michigan 49507
United States
Phone 616 294 1026
Website shoulderinnovations.com

Stock Details

Ticker Symbol SI
Exchange NYSE
Stock Type Common Stock
Fiscal Year January - December
Reporting Currency USD
IPO Price $15.00
CIK Code 0001699350
CUSIP Number 82837P408
ISIN Number US82837P4081
Employer ID 27-0538764
SIC Code 3841

Key Executives

Name Position
Robert Ball Chief Executive Officer and Executive Chairman
Jeffrey Points Chief Financial Officer
Matthew Ahearn Chief Operating Officer and Director
David L. Blue Chief Customer Experience Officer
Paul Buckman Director
Michael Carusi Director
Geoff Pardo Director
Kevin Sidow Director
Casey Tansey Director

Latest SEC Filings

Date Type Title
Aug 8, 2025 SCHEDULE 13G Filing
Aug 5, 2025 SCHEDULE 13D Filing
Aug 4, 2025 8-K Current Report
Aug 1, 2025 S-8 Securities to be offered to employees in employee benefit plans
Aug 1, 2025 424B4 Prospectus
Jul 31, 2025 FWP Free Writing Prospectus
Jul 30, 2025 EFFECT Notice of Effectiveness
Jul 30, 2025 CERT Certification by an exchange approving securities for listing
Jul 30, 2025 8-A12B Registration of securities
Jul 25, 2025 S-1/A [Amend] General form for registration of securities under the Securities Act of 1933